Just after Genzyme announced that it signed a confidentiality agreement with Sanofi Aventis to allow the French drugmaker to examine its books, leaks about the potential deal started pouring out. The numbers and details vary, s…
Netflix, whose DVD-by-mail service hastened the demise of several video rental chains, may soon find itself under siege from Amazon. The world’s largest online retailer appears to be on the verge of launching its own unlimited …
Wall Street shrugged off instability in Egypt to rally to a two-and-a-half year high Tuesday, boosted by encouraging economic data and better-than-expected corporate earnings.
Continue reading Dow Closes Above …
In a surprise move Tuesday, the FDA rejected Orexigen’s proposed new diet drug Contrave, saying the company needed to run another study of its cardiovascular risks. With this rejection, all three of a slate of similar diet drug…
McDonald’s boosted its profit last year with the launch of new beverages and expansion in emerging markets. Can it keep up the growth this year as food prices rise? Chief Financial Officer Peter Bensen discusses the fast-food g…